About thirty managers belonging to different institutions have visited Bionaturis’ FLYLIFE factory this week. The visit was part of the biotech committee of Corporacion Tecnologica of Andalusia (CTA). Reference people of the biotech sector including members of the Brazilian multinational company Ourofino or Bionaturis’ scientific advisor, professor Vikram Vakharia of Maryland University, among others, have been guided by Bionaturis’ staff to know at first hand how thousands of vaccines can be manufactured in no more than 350 square meters. The secret of Flylife is based on the use of butterfly caterpillars as natural factories to get these cutting-edge vaccines, allowing that more people and producers all over the world may have access to them.
About the visit, Javier Gallastegui -managing director of the company- claims “welcoming these personalities and friends and showing them how we take those vaccines to the world from Jerez is an honor for us”. Nowadays, several multinational companies that work in veterinarian field are evaluating vaccines produced by FLYLIFE technology, representing an outstanding milestone for Spanish Biotechnology.
Juan Jose Infante’s speech
Bionaturis, co-organizer of the committee along with CTA, took part with the conference titled ‘Second Generation Vaccines: Bionaturis’ Strategy’, in which the CSO, Juan Jose Infante, talked about the main vaccines being developed by Bionaturis so far. Infante has pointed out the relevance of the innovation in the research of vaccines and how they are key elements not only to human, but also to animal health in order to control devastating pandemics. A sustainable and more affordable manufacturing and developing process is essential to guarantee a broad access to high-benefit vaccines, something that Bionaturis gets with its platform FLYLIFE.
Corporacion Tecnologica of Andalusia (CTA) is a private foundation promoted by the […]